Amgen has announced that David Reese will replace outgoing executive vice president of research and development, Sean Harper.
Reese, who has been with Amgen since 2005, will be promoted from his current role as senior vice president of translational sciences and oncology, effective immediately. During his time at the company, Reese has worked in development, medical sciences, as well as discovery research and, in his latest role, translational sciences.
“Dave is a medical oncologist who was on faculty at UCLA when I recruited him to Amgen and he served in a variety of increasingly senior roles until his hire in 2005,” said Reese’s predecessor Sean Harper in an investor call last week.
“He has my full confidence and that of my team as the next head of R&D for Amgen. I’ll be staying around through the end of the year to ensure a smooth transition,” he added.
Prior to his time at Amgen, Reese worked at the University of California in both Los Angeles and San Francisco. He has also held posts at the Clinical Research for the Breast Cancer International Research Group (BCIRG) and at Translational Research International (TORI).
Reese is a graduate of Harvard College and the University of Cincinnati College of Medicine.